New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
08:10 EDTTRNTrinity Industries price target raised to $105 from $90 at KeyBanc
KeyBanc increased its price target on Trinity as the firm is increasingly confident that the domestic railcar cycle has gained momentum. The firm expects analysts' estimates for the company to rise going forward, It keeps a Buy rating on the shares.
News For TRN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2015
11:15 EDTTRNTrinity Industries sees extended rail car cycle due to diverse market demand
Comments from Q2 earnings conference call.
July 23, 2015
19:06 EDTTRNOn The Fly: After Hours Movers
UP AFTER EARNINGS: Amazon (AMZN), up 17.2%... Marketo (MKTO), up 15.4%... Juniper Networks (JNPR), up 9.9%... NetGear (NTGR), up 9.2%... Qlik Technologies (QLIK), up 9.1%... LogMeIn (LOGM), up 9.9%... Pandora (P), up 10.3%... Mitek Systems (MITK), up 7.8%... Proofpoint (PFPT), up 5.1%... Supreme Industries (STS), up 4.7%... Skyworks (SWKS), up 3.6%... IGI Laboratories (IG), up 3.7%... Maxim Integrated Products (MXIM), up 4.1%... Boyd Gaming (BYD), up 4.1%... Trinity Industries (TRN), up 5%... Trinity Industries (N), up 3.2%... Starbucks (SBUX), up 4.5%. ALSO HIGHER: Qorvo (QRVO), up 2.7% after Skyworks reported quarterly results. DOWN AFTER EARNINGS: TrueCar (TRUE), down 33.1% after reporting quarterly results and cutting fiscal 2015 revenue guidance... Tripadvisor (TRIP), down 9.2%... Align Technology (ALGN), down 7.4%... Capital One (COF), down 4.9%... PMC-Sierra (PMCS), down 9.1%... athenahealth (ATHN), down 2.1%. ALSO LOWER: Sunesis Pharmaceuticals (SNSS), down 59.7% after giving vosaroxin regulatory update... Avalanche Biotechnologies (AAVL), down 5.6% after CEO Thomas Chalberg, Jr., Ph.D. resigns and Hans Hull name interim CEO.
16:35 EDTTRNTrinity Industries raises FY15 EPS to $4.45-$4.75 from $4.10-$4.45
Consensus is $4.43.
16:33 EDTTRNTrinity Industries reports Q2 EPS $1.33, consensus $1.09
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use